Biogen Reports Progress on Corporate Responsibility Priorities
May 02, 2024 07:30 ET
|
Biogen Inc.
Efforts focused on four areas: access and health equity, workforce and DE&I, community impact and the environment CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB)...
Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
April 25, 2024 16:05 ET
|
Biogen Inc.
CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE™ to the reference product ROACTEMRA® CAMBRIDGE, Mass., April 25, 2024 (GLOBE...
Alzheimer's Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032
April 18, 2024 11:00 ET
|
Precedence Research
Ottawa, April 18, 2024 (GLOBE NEWSWIRE) -- The global alzheimer's therapeutics market size was valued at USD 4.82 billion in 2023 and is predicted to hit around USD 7.52 billion by 2031, a study...
Global Quantum Technology Industry Research 2024: Market will Reach $61.3 Billion by 2029 - Developments in the Areas of Hybrid Quantum Applications, Quantum Machine Learning, and Much More
April 17, 2024 06:02 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Quantum Technology Market by Computing, Communications, Imaging, Security, Sensing, Modeling and Simulation 2024 - 2029" report has been added to ...
Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer
April 16, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 16, 2024 (GLOBE NEWSWIRE) -- Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly...
Global Pulmonary Fibrosis Biomarkers Market Size To Exceed USD 6.1 Billion By 2033 | CAGR of 4.3%
April 12, 2024 09:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 12, 2024 (GLOBE NEWSWIRE) -- The Global Pulmonary Fibrosis Biomarkers Market Size is to Grow from USD 4.0 Billion in 2023 to USD 6.1 Billion by 2033, at a Compound...
Lily AI’s Co-Founders Purva Gupta and Sowmiya Chocka Narayanan Make Inc.’s 2024 Female Founders List
April 09, 2024 09:15 ET
|
Lily AI
Lily AI’s Co-Founders Purva Gupta and Sowmiya Chocka Narayanan Make Inc.’s 2024 Female Founders List.
Global Regenerative Medicine Industry Research 2023-2028: Market Driven by Wide Scope in New Therapeutic Areas and Collaborations and Partnerships
April 03, 2024 09:43 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application...
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
April 02, 2024 07:00 ET
|
Avalo Therapeutics
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent DirectorsBoard of Director appointments in conjunction with Avalo’s recent acquisition of...
Dyne Therapeutics Announces CEO Transition
March 25, 2024 07:30 ET
|
Dyne Therapeutics, Inc.
- John Cox, Industry Leader with Global Experience in Rare Disease Commercialization, Joins Dyne as President and CEO - WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc....